Key facts
- Cogensus’s last known valuation is $8.0M (Nov 2025).
- It has raised $520K; the latest was Corporate ($250K) in Nov 2025.
- Notable investors include Caduceus Capital Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cogensus
- ·The full record, as it builds
Funding rounds
No funding rounds for Cogensus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cogensus
Developer of a cognitive health engagement platform designed to support and monitor brain health in older adults. The company's platform offers personalized cognitive exercises, social interaction features, progress tracking, remote monitoring capabilities and data analytics, enabling healthcare providers, caregivers and families to proactively address cognitive decline, reduce risks associated with loneliness and improve overall brain health outcomes for the aging population.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2024
- Employees
- 12
- Website
- cogensus.com/
- Ownership
- Privately Held (backing)
Cogensus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cogensus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cogensus in its N-PORT filings yet. We sweep new filings monthly.